The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myeloma MA Dimopoulos, M Roussou, M Gkotzamanidou, N Nikitas, E Psimenou, ... Leukemia 27 (2), 423-429, 2013 | 195 | 2013 |
Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 189 | 2021 |
A phase 1/2 study of lenalidomide with low-dose oral cyclophosphamide and low-dose dexamethasone (RdC) in AL amyloidosis E Kastritis, E Terpos, M Roussou, M Gavriatopoulou, C Pamboukas, ... Blood, The Journal of the American Society of Hematology 119 (23), 5384-5390, 2012 | 119 | 2012 |
Cytomegalovirus reactivation in a general, nonimmunosuppressed intensive care unit population: incidence, risk factors, associations with organ dysfunction, and inflammatory … FG Frantzeskaki, ES Karampi, C Kottaridi, M Alepaki, C Routsi, M Tzanela, ... Journal of critical care 30 (2), 276-281, 2015 | 108 | 2015 |
Effect of antiplatelet therapy on survival and organ support–free days in critically ill patients with COVID-19: a randomized clinical trial CA Bradbury, PR Lawler, SJ Stanworth, BJ McVerry, Z McQuilten, ... Jama 327 (13), 1247, 2022 | 84 | 2022 |
XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with … D Pectasides, G Papaxoinis, KT Kalogeras, AG Eleftheraki, I Xanthakis, ... BMC cancer 12, 1-10, 2012 | 84 | 2012 |
Long-term (180-day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, A Kidwai, ... Jama 329 (1), 39-51, 2023 | 81 | 2023 |
A case of COVID-19 reinfection in the UK J West, S Everden, N Nikitas Clinical medicine 21 (1), e52, 2021 | 75 | 2021 |
Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression E Razis, KT Kalogeras, V Kotoula, AG Eleftheraki, N Nikitas, R Kronenwett, ... Clinical breast cancer 12 (3), 183-193, 2012 | 73 | 2012 |
Multiple Organ Dysfunction Syndrome NM Gourd, N Nikitas Journal of Intensive Care Medicine, 2019 | 67 | 2019 |
Serial changes in adiponectin and resistin in critically ill patients with sepsis: associations with sepsis phase, severity, and circulating cytokine levels DA Vassiliadi, M Tzanela, A Kotanidou, SE Orfanos, N Nikitas, ... Journal of critical care 27 (4), 400-409, 2012 | 67 | 2012 |
Endometrial cancer: what is new in adjuvant and molecularly targeted therapy? F Zagouri, G Bozas, E Kafantari, M Tsiatas, N Nikitas, MA Dimopoulos, ... Obstetrics and gynecology international 2010, 2010 | 64 | 2010 |
Increased serum lactate dehydrongenase should be included among the variables that define very-high-risk multiple myeloma M Gkotzamanidou, E Kastritis, MRMMM Gavriatopoulou, N Nikitas, D Gika, ... Clinical lymphoma myeloma and leukemia 11 (5), 409-413, 2011 | 59 | 2011 |
Renal impairment is not an independent adverse prognostic factor in patients with multiple myeloma treated upfront with novel agent-based regimens E Eleftherakis-Papapiakovou, E Kastritis, M Roussou, M Gkotzamanidou, ... Leukemia & lymphoma 52 (12), 2299-2303, 2011 | 51 | 2011 |
Circulating angiopoietin‐1 to angiopoietin‐2 ratio is an independent prognostic factor for survival in newly diagnosed patients with multiple myeloma who received therapy with … E Terpos, K Anargyrou, E Katodritou, E Kastritis, A Papatheodorou, ... International Journal of Cancer 130 (3), 735-742, 2012 | 47 | 2012 |
Adipose tissue lipolysis and circulating lipids in acute and subacute critical illness: effects of shock and treatment I Ilias, DA Vassiliadi, M Theodorakopoulou, E Boutati, E Maratou, P Mitrou, ... Journal of Critical Care 29 (6), 1130. e5-1130. e9, 2014 | 45 | 2014 |
Interstitial cortisol obtained by microdialysis in mechanically ventilated septic patients: correlations with total and free serum cortisol DA Vassiliadi, I Ilias, M Tzanela, N Nikitas, M Theodorakopoulou, ... Journal of Critical Care 28 (2), 158-165, 2013 | 34 | 2013 |
Microdialysis-assessed interstitium alterations during sepsis: relationship to stage, infection, and pathogen P Kopterides, N Nikitas, D Vassiliadi, SE Orfanos, M Theodorakopoulou, ... Intensive care medicine 37, 1756-1764, 2011 | 32 | 2011 |
Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support–free days in patients hospitalized with COVID-19: a randomized … S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, K Fareed, ... Jama 329 (14), 1183-1196, 2023 | 28 | 2023 |
Red blood cell transfusion affects microdialysis-assessed interstitial lactate/pyruvate ratio in critically ill patients with late sepsis P Kopterides, M Theodorakopoulou, N Nikitas, I Ilias, DA Vassiliadi, ... Intensive care medicine 38, 1843-1850, 2012 | 28 | 2012 |